155 related articles for article (PubMed ID: 21847800)
1. Utilizing Medicare claims data for real‐time drug safety evaluations:is it feasible?
Hartzema AG; Racoosin JA; MaCurdy TE; Gibbs JM; Kelman JA
Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):684-8. PubMed ID: 21847800
[TBL] [Abstract][Full Text] [Related]
2. Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
Smith MY; Sabidó-Espin M; Trochanov A; Samuelson M; Guedes S; Corvino FA; Richy FF
J Manag Care Spec Pharm; 2015 Aug; 21(8):650-60. PubMed ID: 26233537
[TBL] [Abstract][Full Text] [Related]
3. Postmarketing surveillance of medical devices using Medicare claims.
Malenka DJ; Kaplan AV; Sharp SM; Wennberg JE
Health Aff (Millwood); 2005; 24(4):928-37. PubMed ID: 16012135
[TBL] [Abstract][Full Text] [Related]
4. Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials.
Brennan JM; Wruck L; Pencina MJ; Clare RM; Lopes RD; Alexander JH; O'Brien S; Krucoff M; Rao SV; Wang TY; Curtis LH; Newby LK; Granger CB; Patel M; Mahaffey K; Ross JS; Normand SL; Eloff BC; Caños DA; Lokhnygina YV; Roe MT; Califf RM; Marinac-Dabic D; Peterson ED
Am Heart J; 2019 Dec; 218():110-122. PubMed ID: 31726314
[TBL] [Abstract][Full Text] [Related]
5. Identifying Cancer-Directed Surgeries in Medicare Claims: A Validation Study Using SEER-Medicare Data.
Lavery JA; Lipitz-Snyderman A; Li DG; Bach PB; Panageas KS
JCO Clin Cancer Inform; 2019 Feb; 3():1-24. PubMed ID: 30715928
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
Morrato EH; Staffa JA
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
[TBL] [Abstract][Full Text] [Related]
7. The medical license number accurately identifies the prescribing physician in a large pharmacy claims database.
Brookhart MA; Avorn J; Polinksi JM; Brown TV; Mogun H; Solomon DH
Med Care; 2007 Sep; 45(9):907-10. PubMed ID: 17712263
[TBL] [Abstract][Full Text] [Related]
8. Developing a quality improvement database using health insurance data: a guided tour with application to Medicare's National Claims History file.
Parente ST; Weiner JP; Garnick DW; Richards TM; Fowles J; Lawthers AG; Chandler P; Palmer RH
Am J Med Qual; 1995; 10(4):162-76. PubMed ID: 8547795
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of validated methods for identifying erythema multiforme major/minor/not otherwise specified, Stevens-Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data.
Schneider G; Kachroo S; Jones N; Crean S; Rotella P; Avetisyan R; Reynolds MW
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():236-9. PubMed ID: 22262611
[TBL] [Abstract][Full Text] [Related]
10. Is doc-specific data next?: Ruling could pave way for release of physicians' Medicare claims information.
Carlson J
Mod Healthc; 2013 Jul; 43(26):20-1. PubMed ID: 23878906
[No Abstract] [Full Text] [Related]
11. A review of the Ghana National Health Insurance Scheme claims database: possibilities and limits for drug utilization research.
Ankrah D; Hallas J; Odei J; Asenso-Boadi F; Dsane-Selby L; Donneyong M
Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):18-27. PubMed ID: 30260590
[TBL] [Abstract][Full Text] [Related]
12. Changing physician behavior: does medical review of Part B Medicare claims make a difference?
Nyman JA; Feldman R; Shapiro J; Grogan C; Link D
Inquiry; 1990; 27(2):127-37. PubMed ID: 2142131
[TBL] [Abstract][Full Text] [Related]
13. The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology.
Leonard CE; Brensinger CM; Nam YH; Bilker WB; Barosso GM; Mangaali MJ; Hennessy S
BMC Health Serv Res; 2017 Apr; 17(1):304. PubMed ID: 28446159
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the claim percent gross margin earned by Texas community independent pharmacies for dual-eligible beneficiary claims before and after Medicare Part D.
Winegar AL; Shepherd MD; Lawson KA; Richards KM
J Am Pharm Assoc (2003); 2009; 49(5):617-22. PubMed ID: 19748868
[TBL] [Abstract][Full Text] [Related]
15. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
Starner CI; Norman SA; Reynolds RG; Gleason PP
Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
[TBL] [Abstract][Full Text] [Related]
16. Database and Registry Research in Orthopaedic Surgery: Part I: Claims-Based Data.
Pugely AJ; Martin CT; Harwood J; Ong KL; Bozic KJ; Callaghan JJ
J Bone Joint Surg Am; 2015 Aug; 97(15):1278-87. PubMed ID: 26246263
[TBL] [Abstract][Full Text] [Related]
17. Assessing performance of sequential analysis methods for active drug safety surveillance using observational data.
Zhou X; Bao W; Gaffney M; Shen R; Young S; Bate A
J Biopharm Stat; 2018; 28(4):668-681. PubMed ID: 29157113
[TBL] [Abstract][Full Text] [Related]
18. Results of provider self-adjudication using the prudent layperson standard compared with the managed care organization's emergency department claim review process.
Shesser R; Holtermann K; Smith J; Braun J
Ann Emerg Med; 2000 Sep; 36(3):212-8. PubMed ID: 10969222
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic rate estimation from Medicare records: Dependence on claim numbers and latent clinical features.
Hogans B; Siaton B; Sorkin J
J Biomed Inform; 2023 Sep; 145():104463. PubMed ID: 37517509
[TBL] [Abstract][Full Text] [Related]
20. Identifying comorbidities in home health care patients: does the Outcome and Assessment Information Set have incremental value to Medicare claims data?
Koroukian SM; Scharpf T; Bakaki PM; Madigan E
Home Health Care Serv Q; 2011 Jan; 30(1):1-9. PubMed ID: 21328117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
